Elevation of liver function tests (LFTs) has been noted in patients treated with sirolimus. However, in the United States [1] and global phase 3 trials, [2] elevation of LFTs, specifically of AST ...
Healthy volunteers in Surrozen’s two phase 1 clinical trials have experienced treatment-related adverse events, leading to a voluntary pause on one study and some soul searching on the biotech’s ...
Annabelle, an 18-year-old white woman, was referred by her primary care provider to our gastroenterology practice for markedly elevated serum transaminase levels. Her mother and grandmother ...